# Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa

> **NCT01715922** · PHASE2,PHASE3 · UNKNOWN · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 41 (actual)

## Conditions studied

- Cryptococcal Meningitis
- HIV

## Interventions

- **DRUG:** Fluconazole
- **DRUG:** Flucytosine
- **PROCEDURE:** lumbar punctures

## Key facts

- **NCT ID:** NCT01715922
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2015-09
- **Final completion:** 2016-09
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2016-07-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01715922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01715922, "Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01715922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*